Mantle Cell Lymphoma Treatment Market
According to Intent Market Research, the Mantle Cell Lymphoma Treatment Market is expected to grow from USD 2.6 Billion in 2024-e at a CAGR of 12.2% to touch USD 5.2 Billion by 2030. The Mantle Cell Lymphoma Treatment Market is dominated by key players such as AstraZeneca plc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Merck & Co., Inc., and Janssen Pharmaceuticals, Inc. (Johnson & Johnson).